Antioxidant activities and oxidative stress byproducts in human hypertension

Hypertension

Volumn 41, Issue 5, 2003, Pages 1096-1101

  Redón, Josep ^b   Oliva, Maria R ^a   Tormos, Carmen ^a   Giner, Vicente ^b   Chaves, Javier ^b   Iradi, Antonio ^a   Sáez, Guillermo T ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Antioxidants; DNA; Hypertension, obesity; Hypertension, renovascular; Oxidative stress; Risk factors

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CATALASE; DEOXYRIBONUCLEOPROTEIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD; BLOOD PRESSURE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANTIOXIDANTS; BLOOD PRESSURE; CATALASE; DEOXYGUANOSINE; DNA; DNA, MITOCHONDRIAL; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERTENSION; MALE; MALONDIALDEHYDE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 0038673091     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000068370.21009.38     Document Type: Article

References (30)

1. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis?. Circulation. 2002;105:2107-2111.
2. Chilsom GM, Steimberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med. 2000;28:1815-1826.
3. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular disease: the role of oxidant stress. Circ Res. 2000;87:840-844.
4. Wu L, Jourlink BH. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension. 2002;39:809-814.
5. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 2001;37:541-546.
6. Trolliet MR, Rudd MA, Loscalzo J. Oxidative stress and renal dysfunction in salt-sensitive hypertension. Kidney Blood Press Res. 2001; 24:116-123.
7. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension. 2001;37:554-560.
8. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A. 1991;88:10045-10048.
9. Romero JC, Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999;34:943-949.
10. Raij L. Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension. 1998;31:189-193.
11. McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension: the role of superoxide anion. Hypertension. 1999;34:539-545.
12. Orie NN, Zidek W, Tepel M. Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens. 1999;12:1169-1174.
13. Yasunari K, Maeda K, Nakamura M, Yoshikawa J. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reactive protein. Hypertension. 2002;39:777-780.
14. Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxo-dG. Nature. 1999;349:431-434.
15. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1997; 157:2413-2447.
16. Brigelius R, Muckel C, Akerboom TPM, Sies H. Identification and quantitation of glutathione in hepatic protein mixed disulfides and its relation to glutathione disulfides. Biochem Pharmacol. 1983;32:2529-2534.
17. Navarro J, Obrador E, Pellicer JA, Asensi M, Viña J, Estrela JM. Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radic Biol Med. 1997;22:1203-1209.
18. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN Jr, Sunderman FW Jr. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem. 1987;33:214-220.
19. McCord JM, Fridowich I. The reduction of cytochrome C by milk xanthine oxidase. J Biol Chem. 1968;243:5753-5760.
20. Clairbone A. Catalase activity. In: Green-Wald RA, ed. Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC Press Inc; 1986:283-284.
21. Muñiz P, Valls V, Perez-Broseta C, Iradi A, Climent JV, Oliva MR, Sáez GT. The role of 8-hydroxy-2′-deoxyguanosine in rifamycin-induced DNA damage. Free Radic Biol Med. 1995;18:747-755.
22. Bland JM, Altmann DG. Statistical method for assessing agreement between two methods of clinical measurements. Lancet. 1986;1:307-310.
23. Packer L. Cell regulation by thiol antioxidants: from glutathione to lipoate to anethole dithiolethione. In: Packer L. Traber MG. Xin W, eds. Proceedings of the International Symposium on Natural Antioxidants Molecular Mechanisms and Health Effects. Champaign, Ill: AOCS Press; 1995:223-235.
24. Griffiths NR, Moller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Haenen G, Hoberg AM, Loft S, Lunec J, Olinski R, Parry J, Pompella A, Poulsen H, Verhagen H, Astley SB. Biomarkers. Mol Aspects Med. 2002;23:101-208.
25. Fukui T, Ishizawa N, Rajagopalan S, Laursen JB, Capers Q IV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45-51.
26. Suzuki H, Delano FA, Parks DA Jamshidi N, Granger DN Ishii H Suematsu M, Zweifac BW, Schmid-Schonbein GW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA. 1998;95:4754-4759.
27. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int. 1998;54:775-784.
28. Steinberg D, Parthasarthy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
29. Frenkel K. Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther. 1992;53:127-166.
30. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. 1995;268: L699-L722.